Surrozen (SRZN) Current Leases (2020 - 2026)
Surrozen (SRZN) recorded quarterly Current Leases of $1.9 million in Q1 2026, up 49.38% quarter-over-quarter from $1.3 million in Q4 2025, and up 61.93% on a YoY basis from $1.2 million in Q1 2025.
Surrozen (SRZN) Current Leases (2020 - 2026) Analysis & Trends
Surrozen's Current Leases history runs 7 years deep, the most recent figure standing at $1.9 million for Q1 2026.
- In Q1 2026, Current Leases rose 61.93% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $1.9 million (up 61.93% YoY), while the FY2025 annual figure was $1.3 million, down 29.47% from the prior year.
- Current Leases was $1.9 million for Q1 2026 at Surrozen, up from $1.3 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $2.6 million in Q1 2024 to a low of $1.2 million in Q1 2025.
- Historically, Current Leases has averaged $1.9 million across 5 years, with a median of $2.1 million in 2022.
- The sharpest annual moves came in 2025 and 2026: Current Leases slumped 53.57% in 2025, then surged 61.93% in 2026.
- A 5-year view of Current Leases shows it stood at $2.2 million in 2022, then rose by 12.17% to $2.5 million in 2023, then slipped by 26.75% to $1.8 million in 2024, then retreated by 29.47% to $1.3 million in 2025, then surged by 49.38% to $1.9 million in 2026.
- The last three Current Leases figures came in at $1.9 million (Q1 2026), $1.3 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Surrozen | 225,877.86 | -106.68 Mn | - | 1.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.93 Mn |
| Dec 31, 2025 | 1.29 Mn |
| Sep 30, 2025 | 1.24 Mn |
| Jun 30, 2025 | 1.20 Mn |
| Mar 31, 2025 | 1.19 Mn |
| Dec 31, 2024 | 1.83 Mn |
| Sep 30, 2024 | 1.53 Mn |
| Jun 30, 2024 | 2.17 Mn |
| Mar 31, 2024 | 2.56 Mn |
| Dec 31, 2023 | 2.50 Mn |
| Sep 30, 2023 | 2.43 Mn |
| Jun 30, 2023 | 2.36 Mn |
| Mar 31, 2023 | 2.29 Mn |
| Dec 31, 2022 | 2.23 Mn |
| Sep 30, 2022 | 2.16 Mn |
| Jun 30, 2022 | 2.09 Mn |
| Mar 31, 2022 | 2.14 Mn |
| Dec 31, 2021 | 2.19 Mn |
| Sep 30, 2021 | 2.22 Mn |
| Dec 31, 2020 | 2.11 Mn |